SCHEMBL29323664

SCHEMBL29323664

C=C(C)c1[nH]c(=O)[nH]c1C

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NSD2 O96028 1/20 0.44
▸ ABL1 P00519 1/20 0.44
▸ GAA P10253 1/20 0.44
▸ IDE P14735 1/20 0.44
▸ RIN1 Q13671 1/20 0.44
▸ TDP1 Q9NUW8 1/20 0.44
▸ L3MBTL1 Q9Y468 1/20 0.44
▸ TYMP P19971 1/20 0.42
▸ PDE4A P27815 7/20 0.41
▸ PDE4B Q07343 7/20 0.41
▸ PDE4C Q08493 7/20 0.41
▸ PDE4D Q08499 7/20 0.41
▸ CYP1A2 P05177 2/20 0.41
▸ CYP3A4 P08684 2/20 0.41
▸ CYP2C9 P11712 1/20 0.41
▸ HPGD P15428 1/20 0.41
▸ ALOX15 P16050 1/20 0.41
▸ TSHR P16473 1/20 0.41
▸ NFKB1 P19838 1/20 0.41
▸ BLM P54132 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3027360 0.73 GAA (0.55) NSD2ABL1GAAIDERIN1
SCHEMBL19043811 0.73 NSD2 (0.39) NSD2ABL1GAAIDERIN1
SCHEMBL9786590 0.71 L3MBTL1 (0.48) NSD2ABL1GAAIDERIN1
SCHEMBL9786577 0.68 L3MBTL1 (0.46) NSD2ABL1GAAIDERIN1
SCHEMBL5419895 0.68 GAA (0.46) NSD2ABL1GAAIDERIN1
SCHEMBL9786655 0.67 GAA (0.41) NSD2ABL1GAAIDERIN1
SCHEMBL10807868 0.66 NSD2 (0.43) NSD2ABL1GAAIDERIN1
SCHEMBL10817190 0.64 TDP1 (0.54) NSD2ABL1GAAIDERIN1
SCHEMBL28705743 0.63 TYMP (0.39) TYMP
SCHEMBL10803886 0.63 ABL1 (0.72) NSD2ABL1GAAIDERIN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3854799-B1 CYCLIC DINUCLEOTIDE ANALOGUE, PHARMACEUTICAL COMPOSITION THEREOF, AND APPLICATION SHANGHAI DE NOVO PHARMATECH CO LTD (CN) 2024-07-17 — — EP disclosed
Send feedback